Latest Breaking News On - Ming yan - Page 13 : comparemela.com

Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CTO Ming Yan sold 20,000 shares of the stock in a transaction on Monday, March 20th. The shares were sold at an average price of $9.29, for a total value of $185,800.00. Following the completion of the sale, the chief technology officer now owns 7,906,053 shares of the […]

Cytek biosciencesPiper sandlerMing yanLazard asset managementGoldman sachs groupMorgan stanleyCytek biosciences company profileRoyal bankCytek biosciences incLife insurance coGet ratingCytek biosciences dailyNasdaq ctkbInsider tradingNsider trades